Loading...
Loading...
All product recalls associated with ASTRAZENECA PHARMACEUTICALS.
Total Recalls
6
Past Year
1
Class I (Serious)
1
Most Recent
Oct 2025
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
Lack of Assurance of Sterility:
Failed Impurities/Degradation Specifications; elevated levels of quality attribute Form L (polymorph).
Presence of Foriegn Tablets/Capsules: customer complaint that an 8-count professional sample bottle labeled as BRILINTA 90 mg tablets contained 5 ZURAMPIC 200 mg tablets, in addition to the expected 8 BRILINTA tablets.